American Journal of Mathematical and Management Sciences

Bayesian statistics has emerged as a powerful tool in healthcare research, particularly in predicting disease outcomes using biomarker data. It offers a significant advantage when it comes to dealing with complex and diverse biomarker data. Biomarkers are crucial in disease prediction as they provide insights into the body's physiologicala and genetical characteristics indicating the progression of a disease or response to treatment. In this situation, we can effectively integrate multiple biomarkers and account for their interrelationships by employing Bayesian models. This will enable us to conduct a holistic evaluation of the risk associated with a disease. In simpler terms, Bayesian statistics allows us to make sense of intricate biomarker information helping us better understand and predict diseases. Further, bayesian statistics facilitates the incorporation of prior knowledge and expert opinions into the predictive modeling process. Priors can be elicited from domain experts or from previous studies by providing a valuable foundation for predictions. As new data becomes available, Bayesian methods update the prior knowledge using likelihood functions allowing for a seamless integration of prior beliefs and observed evidence. This dynamic updating process enables the models to adapt and refine their predictions as more information becomes available.

The application of Bayesian statistics in disease outcome prediction using biomarkers also faces challenges. One challenge is the availability and quality of biomarker data and the other one is the need for standardized methodologies and guidelines for incorporating Bayesian statistics into clinical practice. To overcome these challenges, collaborative efforts between researchers, clinicians, and data scientists are essential. Moreover, addressing challenges related to data availability and standardization will further enhance the application of Bayesian statistics in predicting disease outcomes, leading to improved patient care and better-informed clinical decisions. The proposed aim of this special issue is to provide a complete overview of the current state of Bayesian statistics in predicting disease outcomes using biomarkers and to highlight recent advancements and challenges in this field. This special issue will serve as a platform to showcase innovative approaches, discuss best practices and encourage collaboration among researchers working in this area.

• Bayesian modeling of disease progression using multimodal biomarkers
• Bayesian methods for predicting treatment response based on biomarker data
• Incorporating prior knowledge and expert opinions in Bayesian disease outcome prediction models
• Bayesian hierarchical models for personalized medicine using biomarkers
• Bayesian approaches for handling missing data in disease outcome prediction
• Integration of machine learning and Bayesian statistics in disease outcome prediction
• Bayesian networks for modeling complex biomarker interactions in disease outcomes
• Bayesian inference for survival analysis using biomarker data
• Uncertainty quantification in Bayesian disease outcome prediction models
• Bayesian decision-making frameworks for clinical management based on biomarkers
• Bayesian analysis of longitudinal biomarker data for disease prognosis
• Bayesian methods for predictive modeling in precision oncology.

Instructions for AuthorsSubmit an Article